tiprankstipranks
Trending News
More News >
Albaad Massuot Yitzhak Ltd. (IL:ALBA)
:ALBA
Israel Market
Advertisement

Albaad (ALBA) AI Stock Analysis

Compare
0 Followers

Top Page

IL:ALBA

Albaad

(ALBA)

Rating:74Outperform
Price Target:
2,348.00
▼(-7.45% Downside)
Albaad's overall stock score reflects a stable financial position with an attractive valuation. The company's improving profitability and operational efficiency are positive, but high leverage and slow revenue growth are risks. Technical analysis supports a neutral to slightly positive outlook, enhancing the stock's appeal.

Albaad (ALBA) vs. iShares MSCI Israel ETF (EIS)

Albaad Business Overview & Revenue Model

Company DescriptionAlbaad (ALBA) is a leading manufacturer in the hygiene and personal care industry, specializing in the production of wet wipes, feminine hygiene products, and adult incontinence solutions. The company operates globally, providing high-quality private label and branded products to retailers, distributors, and institutional clients. With a focus on innovation and sustainability, Albaad serves a diverse range of sectors including healthcare, hospitality, and retail.
How the Company Makes MoneyAlbaad generates revenue primarily through the sale of its hygiene products. Its business model relies on manufacturing and supplying wet wipes, feminine hygiene products, and adult incontinence solutions under both private labels and its own brands. Revenue streams are diversified across different market segments, including retail chains, healthcare facilities, and hospitality businesses. The company maintains strategic partnerships with major retailers and distributors worldwide, enhancing its market reach and sales volume. Albaad's focus on innovation and sustainable practices also plays a significant role in attracting clients seeking eco-friendly solutions, which can contribute to its earnings.

Albaad Financial Statement Overview

Summary
Albaad's financial performance is moderate with a stable gross profit margin and improved net profit margin. The high debt-to-equity ratio poses a risk, although there is a noticeable improvement in return on equity. The cash flow is stable but inconsistent growth could be a concern.
Income Statement
72
Positive
Albaad's income statement shows moderate performance with a steady gross profit margin of approximately 20% to 21% over the past years. The net profit margin improved to 2.41% in the TTM period from a negative margin two years ago, indicating a recovery in profitability. The EBIT and EBITDA margins have remained stable, reflecting consistent operational efficiency. However, revenue growth has been slow, with a slight increase in recent periods, suggesting a need for stronger top-line expansion strategies.
Balance Sheet
65
Positive
The balance sheet reveals a high debt-to-equity ratio of about 1.55, indicating significant leverage. While the equity ratio improved slightly in recent periods, it remains moderate at around 28.7% in the TTM. Return on equity has improved to 9.28% in the TTM, up from negative figures two years ago, which signals enhanced profitability. Nonetheless, the high leverage poses potential risks in the event of income volatility.
Cash Flow
70
Positive
Cash flow analysis shows a stable free cash flow with an increase in the TTM period. The operating cash flow to net income ratio is strong, demonstrating efficient cash generation relative to net earnings. However, free cash flow growth has been inconsistent over the years, reflecting fluctuations in capital expenditures and operating cash flow. The company should focus on maintaining consistent cash flow growth to support operations and reduce debt.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.72B1.71B1.45B1.49B1.58B
Gross Profit347.93M344.37M235.00M270.70M418.70M
EBITDA192.42M176.03M91.96M192.56M281.40M
Net Income44.88M30.23M-35.12M-20.34M101.31M
Balance Sheet
Total Assets1.51B1.58B1.60B1.57B1.41B
Cash, Cash Equivalents and Short-Term Investments25.16M19.13M27.19M18.24M34.05M
Total Debt712.92M829.03M836.53M802.11M609.00M
Total Liabilities1.07B1.18B1.24B1.14B927.61M
Stockholders Equity426.68M394.08M346.83M430.25M478.58M
Cash Flow
Free Cash Flow101.60M120.98M-67.58M-38.08M114.28M
Operating Cash Flow152.50M233.23M18.57M52.58M184.72M
Investing Cash Flow-9.51M-110.94M-30.36M-170.24M-22.61M
Financing Cash Flow-135.56M-134.49M20.46M103.68M-149.09M

Albaad Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2537.00
Price Trends
50DMA
2065.12
Positive
100DMA
1920.95
Positive
200DMA
1916.27
Positive
Market Momentum
MACD
44.46
Negative
RSI
80.93
Negative
STOCH
57.05
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:ALBA, the sentiment is Positive. The current price of 2537 is above the 20-day moving average (MA) of 2127.60, above the 50-day MA of 2065.12, and above the 200-day MA of 1916.27, indicating a bullish trend. The MACD of 44.46 indicates Negative momentum. The RSI at 80.93 is Negative, neither overbought nor oversold. The STOCH value of 57.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:ALBA.

Albaad Peers Comparison

Overall Rating
UnderperformOutperform
Sector (70)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
380.60M9.14
70
Outperform
3.02B22.5512.57%4.04%12.72%48.80%
3.85B14.60
1.97%
398.99M8.92
3.61%
247.61M8.31
2.83%
242.66M14.03
1.08%
171.98M11.07
4.65%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:ALBA
Albaad
2,537.00
1,038.00
69.25%
IL:SANO1
Sano
34,500.00
5,217.41
17.82%
IL:AMRK
Amir Mark.
3,327.00
1,095.02
49.06%
IL:AVIV
Aviv
1,884.00
522.09
38.34%
IL:OVRS
Overseas
441.80
105.96
31.55%
IL:LSCO
Lesico
340.70
85.42
33.46%

Albaad Corporate Events

Albaad’s Securities Offering Period Extended to 2025
Feb 13, 2025

Albaad, a company with securities listed on the Tel Aviv Stock Exchange, has announced that the Securities Authority has extended the validity period for offering securities according to its shelf prospectus until November 6, 2025. This extension is expected to impact Albaad’s operational strategy by providing more time for financial maneuvering and potentially improving its market positioning, assuring stakeholders of continued investment opportunities.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 14, 2025